Will NCT07216079 (Sanofi) still show a study completion date of 30 November 2026 or earlier when checked on 30 December 2026?
deadline 2026-12-30
confidence medium
tier 4 evidence
81%PolySignal estimate
Resolution criterion
Yes if, when NCT07216079 is read on clinicaltrials.gov on 30 December 2026, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 30 November 2026 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 8 October 2026: NCT07216079 is registered as ACTIVE_NOT_RECRUITING, sponsored by Sanofi, with 4 participants. Started 2025-10; announced primary completion 2026-11-30, announced study completion 2026-11-30. Record last updated 2025-11-06. The date under test is 2026-11-30. Source: clinicaltrials.gov/study/NCT07216079
What pushes it up
- The trial has completed recruitment with a very small cohort of 4 participants and status ACTIVE_NOT_RECRUITING [1].
- The target completion date of 30 November 2026 is less than two months away, reducing the likelihood of major timeline adjustments [1].
What pushes it down
- Sponsors occasionally update ClinicalTrials.gov records near or just past target dates to extend follow-up periods or final analysis schedules [1].
What would move this number most
Whether Sanofi submits a protocol update extending the study completion date prior to the 30 December 2026 check.
How this number is built
| Deadline | 2026-12-30 |
| Base rate | 80% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 78 · 83 (spread 5 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-08 07:35 |
| Model | gemini-3.6-flash |